Sun Pharmaceutical Industries Limited
₹1,777.70+₹16.70 (+0.95%)
Sun Pharmaceutical Industries Limited’s quoted price sits in the lower half of its reported 52-week range, 13.15% below the high.
NSE · NIDAN.NS · INR
Stock price
Quote as of Oct 29, 2026, 04:29 AM UTC. Cached market data; not a live quote.
One-year closing-price history · INR. Historical prices are not a forecast.
Nidan Laboratories & Healthcare Ltd.’s quoted price sits in the lower half of its reported 52-week range, 47.79% below the high.
52-week range
Go beyond this overview with deeper company research in PortfolioX. Explore more in the app
THE COMPANY BEHIND THE TICKER
Nidan Laboratories & Healthcare Ltd. is an India-based company operating in the healthcare sector, specializing in comprehensive diagnostic services. The company provides an extensive range of pathology services, including biochemistry, hematology, microbiology, cytogenetic, and molecular diagnostic tests. Additionally, it offers a broad spectrum of radiology services such as CT scans, MRI, X-rays, and ultrasounds, along with cardiology and neurology diagnostic services and various health and wellness packages. Nidan Laboratories & Healthcare employs a "one-stop" integrated diagnostic model, serving both retail and institutional clients primarily across Maharashtra, India, particularly within the Mumbai Metropolitan Region. Its operational framework utilizes a "Hub and Spoke" model, featuring a central processing laboratory supported by multiple collection centers and satellite labs, and it is actively expanding its presence into Tier-2 cities through a franchise network.
Latest available per-share figures in INR. The payout ratio compares dividends with earnings.
About this data · PortfolioX market data, also available in the mobile app. Prices are displayed in the listing currency; dividend amounts use the currency shown in that section. Data availability and update times vary.
Page generated Oct 30, 2026, 10:02 AM UTC. Quotes retain their own timestamp above. Missing values appear as a dash. This page is for information only, not personalized investment advice.
KEEP COMPARING
₹1,777.70+₹16.70 (+0.95%)
Sun Pharmaceutical Industries Limited’s quoted price sits in the lower half of its reported 52-week range, 13.15% below the high.
₹9,780.00+₹116.00 (+1.2%)
Divi's Laboratories Limited’s quoted price sits in the upper half of its reported 52-week range, 0.69% below the high.
₹4,613.40+₹33.40 (+0.73%)
Torrent Pharmaceuticals Limited’s quoted price sits in the upper half of its reported 52-week range, 12.13% below the high.
₹2,405.50+₹161.50 (+7.2%)
Laurus Labs Limited’s quoted price sits in the upper half of its reported 52-week range, 0.0% below the high.
₹1,245.50+₹61.10 (+5.16%)
Zydus Lifesciences Limited’s quoted price sits in the upper half of its reported 52-week range, 0.27% below the high.
₹8,448.00+₹248.00 (+3.02%)
Apollo Hospitals Enterprise Limited’s quoted price sits in the upper half of its reported 52-week range, 6.86% below the high.
₹680.00-₹1.75 (-0.26%)
Lenskart Solutions Limited’s quoted price sits in the upper half of its reported 52-week range, 6.21% below the high.
₹1,352.00+₹7.00 (+0.52%)
Dr. Reddy's Laboratories Limited’s quoted price sits in the upper half of its reported 52-week range, 4.45% below the high.